These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30253306)

  • 1. Quantitative 3D Analysis of Coronary Wall Morphology in Heart Transplant Patients: OCT-Assessed Cardiac Allograft Vasculopathy Progression.
    Chen Z; Pazdernik M; Zhang H; Wahle A; Guo Z; Bedanova H; Kautzner J; Melenovsky V; Kovarnik T; Sonka M
    Med Image Anal; 2018 Dec; 50():95-105. PubMed ID: 30253306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of cardiac allograft vasculopathy using highly automated 3-dimensional optical coherence tomography analysis.
    Pazdernik M; Chen Z; Bedanova H; Kautzner J; Melenovsky V; Karmazin V; Malek I; Tomasek A; Ozabalova E; Krejci J; Franekova J; Wahle A; Zhang H; Kovarnik T; Sonka M
    J Heart Lung Transplant; 2018 Aug; 37(8):992-1000. PubMed ID: 29706574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
    Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M
    Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of early changes in the coronary artery microstructure after heart transplantation: A prospective optical coherence tomography study.
    Clemmensen TS; Holm NR; Eiskjær H; Jakobsen L; Berg K; Neghabat O; Løgstrup BB; Christiansen EH; Dijkstra J; Terkelsen CJ; Maeng M; Poulsen SH
    J Heart Lung Transplant; 2018 Apr; 37(4):486-495. PubMed ID: 29128426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy.
    Foldyna B; Sandri M; Luecke C; Garbade J; Gohmann R; Hahn J; Fischer J; Gutberlet M; Lehmkuhl L
    Eur Radiol; 2020 Aug; 30(8):4317-4326. PubMed ID: 32179995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.
    Pazdernik M; Wichterle D; Chen Z; Bedanova H; Kautzner J; Melenovsky V; Karmazin V; Malek I; Stiavnicky P; Tomasek A; Ozabalova E; Krejci J; Wahle A; Zhang H; Kovarnik T; Sonka M
    Clin Transplant; 2020 Feb; 34(2):e13773. PubMed ID: 31859379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Coherence Tomography in the Assessment and Management of Cardiac Allograft Vasculopathy.
    Chatterjee A; Shanmugasundaram M; Lee KS; Kazui T; Rajapreyar IN; Acharya D
    Curr Cardiol Rep; 2024 Aug; 26(8):777-782. PubMed ID: 38864982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study.
    Chih S; Chong AY; Džavík V; So DY; Aleksova N; Wells GA; Bernick J; Overgaard CB; Stadnick E; Mielniczuk LM; Beanlands RSB; Ross HJ
    Circ Heart Fail; 2023 Jun; 16(6):e010173. PubMed ID: 37165901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.
    Pazdernik M; Bedanova H; Chen Z; Kautzner J; Melenovsky V; Malek I; Slavcev A; Bartonova M; Karmazin V; Eckhardt T; Tomasek A; Ozabalova E; Kovarnik T; Wohlfahrt P; Sonka M
    Transpl Immunol; 2021 Apr; 65():101340. PubMed ID: 33069814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical Coherence Tomography for the Early Detection of Coronary Vascular Changes in Children and Adolescents After Cardiac Transplantation: Findings From the International Pediatric OCT Registry.
    McGovern E; Hosking MCK; Balbacid E; Voss C; Berger F; Schubert S; Harris KC
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2492-2501. PubMed ID: 30031706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study.
    Huibers MM; Vink A; Kaldeway J; Huisman A; Timmermans K; Leenders M; Schipper ME; Lahpor JR; Kirkels HJ; Klöpping C; de Jonge N; de Weger RA
    Atherosclerosis; 2014 Oct; 236(2):353-9. PubMed ID: 25128973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of genetics in the development of cardiac allograft vasculopathy.
    Mayerova L; Chaloupka A; Wohlfahrt P; Hubacek JA; Bedanova H; Chen Z; Kautzner J; Melenovsky V; Malek I; Tomasek A; Ozabalova E; Krejci J; Kovarnik T; Sonka M; Pazdernik M
    Bratisl Lek Listy; 2023; 124(3):193-200. PubMed ID: 36598310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study).
    Khandhar SJ; Yamamoto H; Teuteberg JJ; Shullo MA; Bezerra HG; Costa MA; Selzer F; Lee JS; Marroquin OC; McNamara DM; Mulukutla SR; Toma C
    J Heart Lung Transplant; 2013 Jun; 32(6):596-602. PubMed ID: 23499356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a semi-automatic software for optical coherence tomography - analysis in heart transplanted patients.
    Jensen NM; Chen Z; Clemmensen TS; Neghabat O; Holck EN; Pazdernik M; Mogensen LJH; Wahle A; Sonka M; Eiskjær H
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):257-268. PubMed ID: 36109445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early optical coherence tomography evaluation of donor-transmitted atherosclerosis and cardiac allograft vasculopathy: insights from a prospective, single-center study.
    Takahashi T; Kobayashi Y; Saeed O; Vukelic S; Jorde UP; Shin JJ; Patel SR
    J Heart Lung Transplant; 2023 Dec; 42(12):1678-1687. PubMed ID: 37454771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Intimal Neovessels Noted by Optical Coherence Tomography with Cardiac Allograft Vasculopathy.
    Chahal DS; Parikh R; Yoo D; Aje T; Ramani G; Srivastava MC
    Cureus; 2020 Mar; 12(3):e7454. PubMed ID: 32351833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the vasa vasorum and the atherosclerotic changes in cardiac allograft vasculopathy: volumetric analysis.
    Park KH; Kwon TG; Matsuzawa Y; Sun T; Liu Z; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):272-9. PubMed ID: 26657475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-localization of Disturbed Flow Patterns and Occlusive Cardiac Allograft Vasculopathy Lesion Formation in Heart Transplant Patients.
    Timmins LH; Gupta D; Corban MT; Molony DS; Oshinski JN; Samady H; Giddens DP
    Cardiovasc Eng Technol; 2015 Mar; 6(1):25-35. PubMed ID: 26577100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.